Department of Anesthesiology, SUNY-Buffalo, Buffalo, USA.
J Anesth. 2011 Oct;25(5):704-9. doi: 10.1007/s00540-011-1180-x. Epub 2011 Jun 17.
To identify the effects of adding two different doses of dexamethasone on the duration and quality of interscalene block in patients undergoing shoulder surgery in ambulatory surgery settings.
The study design was reviewed and approved by the University at Buffalo Institutional Review Board for Human Subjects. After obtaining informed consent, a total of 90 patients undergoing shoulder surgery using interscalene block with 0.5% bupivacaine (40 mL) were assigned randomly to one of three groups: control patients, "Group C," who received no additive; low dose, "Group L," who received additional dexamethasone 4 mg; and high dose, "Group H," who received dexamethasone 8 mg in addition to 0.5% bupivacaine. Postoperative analgesia was assessed using the numeric rating scores of pain and the postoperative consumption of acetaminophen 325 mg + hydrocodone 7.5 mg tablets. Analysis was by intention to treat. Statistical significance was tested using a two-way analysis of variance and a nonparametric analysis of variance for consumption of analgesics.
Four patients were excluded from the study due to either a failed block or inadequate follow-up. The duration of analgesia was significantly prolonged in both Group L (21.6 ± 2.4 h) and Group H (25.2 ± 1.9 h) compared with Group C (13.3 ± 1.0 h) (p < 0.05). Similarly, the duration of motor block was longer in both Group L (36.7 ± 4.1 h), and Group H (39.2 ± 3.9 h) compared to Group C (24.6 ± 3.3 h) (p < 0.05). Postoperative analgesic consumption for the first 48 h was significantly lower in Group L (6.5 [4-8] tabs) and in Group H (5.5 [4-7] tabs) vs. 9.5 [8-12] tabs in Group C (p < 0.01). There were no adverse events related to dexamethasone during the 4-week follow-up period.
The addition of dexamethasone to bupivacaine significantly prolonged the duration of the motor block and improved the quality of analgesia following interscalene block. There was no difference in the duration of analgesia and motor block between low-dose and high-dose dexamethasone.
在日间手术环境下,确定在接受肩部手术的患者中,加入两种不同剂量的地塞米松对臂丛神经阻滞持续时间和质量的影响。
本研究设计经布法罗大学人类受试者机构审查委员会审查和批准。在获得知情同意后,共有 90 名接受 0.5%布比卡因(40 毫升)行肌间沟阻滞的肩部手术患者被随机分配至三组:对照组(“C 组”),未添加任何添加剂;低剂量组(“L 组”),接受额外的 4 毫克地塞米松;高剂量组(“H 组”),接受 0.5%布比卡因和 8 毫克地塞米松。术后镇痛效果采用疼痛数字评分和术后对乙酰氨基酚 325 毫克+氢可酮 7.5 毫克片剂的消耗量来评估。分析采用意向治疗。使用双因素方差分析和非参数方差分析对镇痛药的消耗量进行统计学意义检验。
由于阻滞失败或随访不足,有 4 名患者被排除在研究之外。与 C 组(13.3 ± 1.0 小时)相比,L 组(21.6 ± 2.4 小时)和 H 组(25.2 ± 1.9 小时)的镇痛持续时间显著延长(p < 0.05)。同样,L 组(36.7 ± 4.1 小时)和 H 组(39.2 ± 3.9 小时)的运动阻滞时间也明显长于 C 组(24.6 ± 3.3 小时)(p < 0.05)。L 组(6.5 [4-8] 片)和 H 组(5.5 [4-7] 片)术后 48 小时内的镇痛药消耗量明显低于 C 组(9.5 [8-12] 片)(p < 0.01)。在 4 周随访期间,未发现与地塞米松相关的不良反应。
在布比卡因中加入地塞米松可显著延长运动阻滞时间,并改善肌间沟阻滞后的镇痛质量。低剂量和高剂量地塞米松对镇痛和运动阻滞的持续时间无差异。